Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer

Stock Information for Agenus Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Agenus Inc.

Contact Levi & Korsinsky by November 5, 2024 Deadline to Join Class Action Against Agenus Inc. (AGEN)
Agenus Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm
Agenus Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN
Class Action Filed Against Agenus Inc. (AGEN) - November 5, 2024 Deadline to Join - Contact Levi & Korsinsky
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Allarity, ZoomInfo, and Agenus and Encourages Investors to Contact the Firm
Agenus Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before November 5, 2024 to Discuss Your Rights - AGEN
Class Action Filed Against Agenus Inc. (AGEN) Seeking Recovery for Investors - Contact Levi & Korsinsky
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.